Essex Investment Management’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-121,040
| Closed | -$2.16M | – | 317 |
|
|
2025
Q1 | $2.16M | Sell |
121,040
-786
| -0.6% | -$14K | 0.45% | 97 |
|
|
2024
Q4 | $3.63M | Sell |
121,826
-40,111
| -25% | -$1.2M | 0.65% | 49 |
|
|
2024
Q3 | $2.53M | Buy |
161,937
+451
| +0.3% | +$7.05K | 0.44% | 100 |
|
|
2024
Q2 | $2.77M | Buy |
+161,486
| New | +$2.77M | 0.52% | 72 |
|
|
2021
Q3 | – | Sell |
-17,036
| Closed | -$3.78M | – | 435 |
|
|
2021
Q2 | $3.78M | Sell |
17,036
-7,250
| -30% | -$1.61M | 0.44% | 71 |
|
|
2021
Q1 | $3.21M | Buy |
24,286
+2,987
| +14% | +$395K | 0.39% | 79 |
|
|
2020
Q4 | $3.69M | Sell |
21,299
-10,535
| -33% | -$1.82M | 0.46% | 65 |
|
|
2020
Q3 | $3.54M | Sell |
31,834
-6,028
| -16% | -$671K | 0.51% | 45 |
|
|
2020
Q2 | $2.25M | Sell |
37,862
-1,506
| -4% | -$89.3K | 0.37% | 82 |
|
|
2020
Q1 | $2.65M | Sell |
39,368
-1,459
| -4% | -$98.2K | 0.54% | 47 |
|
|
2019
Q4 | $3.44M | Buy |
40,827
+1,500
| +4% | +$126K | 0.42% | 62 |
|
|
2019
Q3 | $2.94M | Sell |
39,327
-14,693
| -27% | -$1.1M | 0.42% | 62 |
|
|
2019
Q2 | $3.42M | Sell |
54,020
-53,489
| -50% | -$3.38M | 0.47% | 47 |
|
|
2019
Q1 | $5.18M | Sell |
107,509
-37,159
| -26% | -$1.79M | 0.77% | 25 |
|
|
2018
Q4 | $4.84M | Sell |
144,668
-24,459
| -14% | -$819K | 0.76% | 25 |
|
|
2018
Q3 | $8.86M | Buy |
169,127
+4,550
| +3% | +$238K | 1.04% | 14 |
|
|
2018
Q2 | $5.15M | Sell |
164,577
-795
| -0.5% | -$24.9K | 0.64% | 34 |
|
|
2018
Q1 | $3.61M | Sell |
165,372
-5,865
| -3% | -$128K | 0.47% | 54 |
|
|
2017
Q4 | $3.46M | Buy |
171,237
+88,753
| +108% | +$1.79M | 0.46% | 54 |
|
|
2017
Q3 | $1.64M | Buy |
+82,484
| New | +$1.64M | 0.22% | 151 |
|